| Name | Cvs Pharmacy #00854 |
|---|---|
| Organization Name | Connecticut Cvs Pharmacy Llc |
| Location | 327 Main Avenue, Norwalk, Connecticut 06851 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (203) 847-2351 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
A single intravenous dose of MRG-110, an anti-microRNA drug, significantly reduced miR-92a levels in the blood of healthy humans.
A new study published in the January issue of Cancer Cell provides exciting new information about how to boost the effectiveness of a promising cancer treatment that targets telomeres in an attempt to interfere with the ability of a cancer cell to continuously divide.
RIVA, the fully automated IV compounding system manufactured by Intelligent Hospital Systems (IH Systems), is ahead of competitors in overall performance, meeting business case expectations and customer satisfaction, according to a new study of IV automation systems by independent healthcare research firm KLAS.
VioQuest Pharmaceuticals today announced that the United States Patent and Trademark Office has issued the first patent for the company's investigational product candidate Lenocta (sodium stibogluconate). U.S. Patent No. 7,416,723 entitled "Therapeutic compositions and methods useful in modulating protein tyrosine phosphatases," encompasses novel compositions including Lenocta for the treatment of cancer and a broad range of other diseases.
› Verified 9 days ago
| NPI Number | 1649374547 |
| Organization Name | CONNECTICUT CVS PHARMACY, L.L.C. |
| Doing Business As | CVS PHARMACY # 00854 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 327 Main Ave, Norwalk, CT 06851 |
| Phone Number | 203-847-2896 |
News Archive
A single intravenous dose of MRG-110, an anti-microRNA drug, significantly reduced miR-92a levels in the blood of healthy humans.
A new study published in the January issue of Cancer Cell provides exciting new information about how to boost the effectiveness of a promising cancer treatment that targets telomeres in an attempt to interfere with the ability of a cancer cell to continuously divide.
RIVA, the fully automated IV compounding system manufactured by Intelligent Hospital Systems (IH Systems), is ahead of competitors in overall performance, meeting business case expectations and customer satisfaction, according to a new study of IV automation systems by independent healthcare research firm KLAS.
VioQuest Pharmaceuticals today announced that the United States Patent and Trademark Office has issued the first patent for the company's investigational product candidate Lenocta (sodium stibogluconate). U.S. Patent No. 7,416,723 entitled "Therapeutic compositions and methods useful in modulating protein tyrosine phosphatases," encompasses novel compositions including Lenocta for the treatment of cancer and a broad range of other diseases.
› Verified 9 days ago
News Archive
A single intravenous dose of MRG-110, an anti-microRNA drug, significantly reduced miR-92a levels in the blood of healthy humans.
A new study published in the January issue of Cancer Cell provides exciting new information about how to boost the effectiveness of a promising cancer treatment that targets telomeres in an attempt to interfere with the ability of a cancer cell to continuously divide.
RIVA, the fully automated IV compounding system manufactured by Intelligent Hospital Systems (IH Systems), is ahead of competitors in overall performance, meeting business case expectations and customer satisfaction, according to a new study of IV automation systems by independent healthcare research firm KLAS.
VioQuest Pharmaceuticals today announced that the United States Patent and Trademark Office has issued the first patent for the company's investigational product candidate Lenocta (sodium stibogluconate). U.S. Patent No. 7,416,723 entitled "Therapeutic compositions and methods useful in modulating protein tyrosine phosphatases," encompasses novel compositions including Lenocta for the treatment of cancer and a broad range of other diseases.
› Verified 9 days ago
Hawley Lane Shoes Type: Durable Medical Equipment & Medical Supplies Supplier Location: 499 Westport Ave, Norwalk, Connecticut 06851 Phone: (203) 847-9400 | |
Connecticut Surgical Supplies Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 14 Main St, Norwalk, Connecticut 06851 Phone: (203) 838-2354 | |
Cvs Pharmacy #00854 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 327 Main Avenue, Norwalk, Connecticut 06851 Phone: (203) 847-2351 | |
Cvs Pharmacy #01149 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 696 West Ave, Norwalk, Connecticut 06850 Phone: (203) 866-0949 | |
Cvs Pharmacy #01154 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 6 Willard Rd, Norwalk, Connecticut 06851 Phone: (203) 750-6901 |